BCL2 and breast carcinoma: In our study, in either acquired drug-resistant or intrinsic resistant cell lines, knockdown of OLA1 can cause a decrease in Bcl-2 expression and increase of Bax and cleaved caspase3, indicating improvement of the chemosensitivity of breast cancer.